INHIBITION OF PLATELET ACTIVATION BY THE NOVEL THROMBOXANE RECEPTOR ANTAGONIST BM 13.505

被引：0
|
作者：
PATSCHEKE, H
STEGMEIER, K
HORNBERGER, W
STAIGER, C
NEUGEBAUER, G
机构：
[1] UNIV HEIDELBERG,KLINIKUM MANNHEIM,INST CLIN CHEM,D-6800 MANNHEIM 1,FED REP GER
[2] BOEHRINGER MANNHEIM GMBH,DEPT MED RES,D-6800 MANNHEIM 31,FED REP GER
来源：
THROMBOSIS AND HAEMOSTASIS | 1987年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [21] BM-144, a novel thromboxane A2 receptor antagonist relaxes trachea guinea pig in vitro
    Dogné, JM
    de Leval, X
    Delarge, J
    Rolin, S
    Masereel, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S21 - S21
  • [22] SYNERGISM OF A THROMBOXANE (TX) SYNTHASE INHIBITOR (TSI) AND A TX RECEPTOR ANTAGONIST (TRA) IN REDUCING PLATELET ACTIVATION
    DECKMYN, H
    GRESELE, P
    VANHOUTTE, E
    NENCI, GG
    VERMYLEN, J
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 114 - 114
  • [23] INHIBITORY EFFECTS OF THE SELECTIVE THROMBOXANE RECEPTOR ANTAGONIST BM-13.177 ON PLATELET-AGGREGATION, VASOCONSTRICTION AND SUDDEN-DEATH
    PATSCHEKE, H
    STEGMEIER, K
    MULLERBECKMANN, B
    SPONER, G
    STAIGER, C
    NEUGEBAUER, G
    BIOMEDICA BIOCHIMICA ACTA, 1984, 43 (8-9) : S312 - S318
  • [24] Pharmacological evaluation of BM-573 an original dual thromboxane receptor antagonist and thromboxane synthase inhibitor as novel potent antithrombotic agent.
    Dogné, JMPN
    de Leval, X
    Benoit, P
    Neven, P
    de Leval, L
    Rolin, S
    David, JL
    Masereel, B
    BLOOD, 2001, 98 (11) : 42A - 42A
  • [25] PROTECTIVE EFFECTS OF THE THROMBOXANE RECEPTOR ANTAGONISTS BM-13.177 AND BM-13.505 AGAINST U-46619-INDUCED SUDDEN-DEATH IN RATS
    SMITH, EF
    MCDONALD, J
    PHARMACOLOGY, 1988, 36 (05) : 340 - 347
  • [26] Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin
    Jan Julius Stampfuss
    Karsten Schrör
    Artur-Aron Weber
    Nature Medicine, 2003, 9 : 1447 - 1447
  • [27] A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice
    Cyrus, Tillmann
    Yao, Yuemang
    Ding, Tao
    Dogne, Jean Michel
    Pratico, Domenico
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 561 (1-3) : 105 - 111
  • [28] THE MODIFICATION OF PLATELET-INDUCED CORONARY VASOCONSTRICTION BY A THROMBOXANE RECEPTOR ANTAGONIST
    VERHEGGEN, R
    SCHROR, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (03) : 483 - 490
  • [29] RELATIONSHIP OF DRUG LEVELS AND PLATELET RECEPTOR BLOCKADE CAUSED BY A THROMBOXANE ANTAGONIST
    FRIEDHOFF, LT
    MANNING, J
    FUNKE, PT
    IVASHKIV, E
    TU, J
    COOPER, W
    WILLARD, DA
    CLINICAL RESEARCH, 1986, 34 (02): : A398 - A398
  • [30] Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI)
    Fujita, M
    Seki, T
    Inada, H
    Shimizu, K
    Takahama, A
    Sano, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 771 - 774
12345